Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 02, 2024 16:30 ET
|
Olema Oncology
SAN FRANCISCO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery,...
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 02, 2024 16:15 ET
|
Xilio Therapeutics, Inc.
WALTHAM, Mass., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies...
Dundee Corporation Completes the Redemption of Its Series 2 and Series 3 Preference Shares
October 01, 2024 17:01 ET
|
Dundee Corporation
TORONTO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A) (“Dundee” or the “Company”) announces that it has now completed the redemption of the 1,145,362 outstanding cumulative...
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 01, 2024 16:05 ET
|
X4 Pharmaceuticals
BOSTON, Oct. 01, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective...
ZenaTech Inc., AI Drone and Enterprise SaaS Company, Announces Direct Listing on the Nasdaq Capital Market Under the Symbol ZENA
October 01, 2024 07:30 ET
|
ZenaTech Inc.
TORONTO, Ontario, Oct. 01, 2024 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (“ZenaTech”), a technology company specializing in AI (Artificial Intelligence) drone and enterprise SaaS...
ART SHARE 003 - Extension of the Offer Period of the iconic artwork ‘Abstraktes Bild (809-4)’ by Gerhard Richter
October 01, 2024 02:17 ET
|
Art Share 003
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR ANY OTHER STATE OR...
FTAI Aviation Announces Full Redemption of Outstanding 8.25% Fixed to Floating Rate Series A Cumulative Perpetual Redeemable Preferred Shares
September 30, 2024 17:00 ET
|
FTAI Aviation Ltd.
NEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) -- FTAI Aviation Ltd. (NASDAQ: FTAI; “FTAI Aviation” or the “Company”) announced today that it will redeem all of the Company’s outstanding 4,180,000...
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 30, 2024 16:01 ET
|
C4 Therapeutics, Inc.
WATERTOWN, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation...
Biometric Seat Technology Market Is Expected To Reach a Revenue Of USD 862.7 Mn By 2033, At 13.6% CAGR: Dimension Market Research
September 30, 2024 13:59 ET
|
Dimension Market Research
New York, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Overview: The Global Biometric Seat Technology Market size is expected to reach USD 274.0 million by 2024 and is further anticipated to reach USD...
MSTX, The First Leveraged MicroStrategy ETF in the U.S. Surpasses $400 Million
September 30, 2024 02:00 ET
|
Defiance ETFs
MSTX, The First Leveraged MicroStrategy ETF in the U.S. Surpasses $400 Million